September 18, 2026

Every electron counts: most detailed protein structure to date revealed

Every electron counts: most detailed protein structure to date revealed

Researchers have used advanced X-ray crystallography methods to determine the structure of the archaeal rubredoxin protein at unprecedented resolution

The image shows a valence electron deformation map of archaeal rubredoxin at 0.43 Ångström resolution. The rubredoxin protein model (sticks) is surrounded by the electron density map (blue to red: low to high density). This valence electron deformation map derived from model refinement reveals electrons in the midpoint of chemical bonds and (valence) electron lone pairs. Credit: Ashwin Chari/Max Planck Institute for Multidisciplinary Sciences and Gleb Bourenkov/EMBL

Summary

  • Researchers have determined the structure of the protein rubredoxin at 0.43 Ångström resolution, the highest resolution ever achieved for a protein structure.
  • These findings and methodology could now allow researchers to routinely apply advanced quantum crystallography methods to the investigation of biological macromolecules, given accurate X-ray diffraction data.
  • Gaining deep insights into enzyme-catalysed reactions through this approach opens the door to developing drugs to treat human diseases and creating designer enzymes for use in chemistry, material science, and industrial applications.

Proteins are high-performance molecular machines that carry out nearly every biochemical function inside living cells. To understand how they achieve this, scientists often look into their detailed atomic structure, which holds important clues to their activity. The more precision they can achieve while doing this, the deeper the insight they might potentially gain into the chemical principles that underlie protein structure and ultimately function.  

Marking a major advancement in X-ray crystallography, scientists headed by Ashwin Chari from the Max Planck Institute for Multidisciplinary Sciences (Göttingen, Germany), Gleb Bourenkov from EMBL Hamburg (Hamburg, Germany), Clemens Schulze-Briese from DECTRIS (Baden, Switzerland), Paulina Maria Dominiak from the University of Warsaw (Poland) and Gérard Bricogne from Global Phasing Ltd. (Cambridge, UK) have determined the structure of the archaeal rubredoxin protein at a resolution of 0.43 Å. 

“This, to the best of our knowledge, represents the highest resolution protein structure determined yet,” explained Ashwin Chari. “This has been enabled by a series of technical innovations and streamlined procedures. We have combined cutting-edge X-ray crystallography with advanced quantum-chemical models, bridging the gap between structural biology and quantum chemistry.” The results have now been published in Acta Crystallographica Section D, Structural Biology.

A record made possible by advanced instrumentation and protocols

Previous experiments by Chari, Bricogne, and Bourenkov laid the groundwork for this resolution record. There, the scientists investigated how X-rays alter protein structure and how radiation damage interferes with atomic model refinement and interpretation. During these experiments, the researchers came up with a ‘resolution-in-dose’ approach, which relied on low-dose data collection protocols on large protein crystals bathed in a ‘top-hat’ beam, which ultimately allowed the scientists to reach sub-Ångström resolutions.

The new study made use of one of the world’s brightest X-ray radiation sources: PETRA III at DESY in Hamburg (Germany). To collect the high-quality data that led to the resolution record, the scientists used the beamline P14 provided by EMBL Hamburg. This produces a tailored X-ray beam with a uniform radiation intensity, known as a ‘top-hat’ beam. Its advantage: the size and shape can be adjusted before the start of every data collection to match the dimensions of each protein crystal. This allows precise control over the X-ray dose delivered to the sample – just as the ‘resolution-in-dose’ approach suggests.

The data collection and processing were carried out according to advanced protocols created on-the-fly by Global Phasing’s workflow software, tailored to each individual sample and designed to produce high data quality.

What X-rays revealed about the protein

The high-resolution X-ray crystallographic data allowed the team to determine accurate nuclear positions of atoms within the structure, including all hydrogen atoms. Beyond that, the accuracy of the electron densities derived from these data revealed quantum mechanical phenomena directly from the experimental structure, including electrons in the mid-point of chemical bonds and atomic partial charges.

“This observation indicates that ‘spherical’ scattering factors commonly used to refine atomic models of biological macromolecules are inadequate to describe the structural results at such high resolutions,” said Dominiak. To adequately explain the experimental structure and electron densities, the team made use of so-called ‘aspherical’ scattering factors in order to account for the observed quantum mechanical phenomena. 

“These findings are of paramount importance to our interest in precisely mapping the role of local electric fields in enzymes and visualising their function during reactions,” said Chari. “Extrapolating our findings and methodology leads us to anticipate that, with accurate X-ray diffraction data, it should now be possible to routinely perform quantum crystallography on biological macromolecules. The long-term goal is to gain deep insights into enzyme-catalysed reactions to support future achievements in chemistry, materials science, and medicine.”

The studies were the result of long-term collaborations with beamline scientists from EMBL, crystallographic software developers from Global Phasing Ltd., the X-ray detector company DECTRIS, quantum crystallographers from the University of Warsaw, as well as experts in biochemistry, X-ray crystallography and interpretation from the Max Planck Institute for Multidisciplinary Sciences.


This article was adapted from a press release published by the Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. 


Source article(s)

Towards routine accurate electron-density studies of biological macromolecules.

Paknia E., et al.

Acta Crystallogr. D Struct. Biol 12 August 2026

10.1107/S2059798326007448

Radiation damage in sub-Ångström resolution macromolecular crystallography: a low-dose study.

Bourenkov G., et al.

Acta Crystallogr. D Struct. Biol 13 April 2026

10.1107/S205979832600269X

Our latest News

discover more
Heidelberg Medical Students Remain at the Very Top in Germany

Heidelberg Medical Students Remain at the Very Top in Germany

In the first phase of the medical exams, students at Heidelberg University’s Faculty of Medicine once again achieved excellent results: In the so-called “Physikum,” the state exam in medical theory, they ranked first in Germany—for the fifth consecutive year. Full Text in German below. Heidelberger Medizin-Studierende weiter absolute Spitze in Deutschland Im ersten Abschnitt der […]

Heisenberg Professorship for Aurélie Ernst

Heisenberg Professorship for Aurélie Ernst

With funding from the German Research Foundation’s (DFG) Heisenberg Program, DKFZ researcher Aurélie Ernst aims to investigate how massive changes in the genome contribute to the development of cancer. Her research focuses on a phenomenon known as chromothripsis – a catastrophic event in the genome in which chromosomes break apart and are reassembled incorrectly. In […]

New Publication by Gen-H: Multi-plasmid antibiotic-free fermentation

New Publication by Gen-H: Multi-plasmid antibiotic-free fermentation

Our latest publication demonstrates a robust strategy for antibiotic-free maintenance of multiple plasmids using orthogonal conditional complementation. You can read the article here. Key highlights: ✅ Maintenance of two plasmids without antibiotics or resistance markers✅ Functionality in non-supplemented media✅ Flexible one- or two-plasmid configurations using orthogonal inducible promoters✅ Productivity equivalent or superior to conventional antibiotic-selected […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp